SlideShare a Scribd company logo
1 of 4
Acetogenins, MIR, &
  Quantification of
Cherimoya Leaf CO2
 Extract (CLCO2E)
     20 February 2013
Can Acetogenins (in total)
        be Quantified by MIR ?




Acetogenins from the Seeds of the Custard Apple (Annona squamosa L.) and
their Health Outcomes, Nuts and Seeds in Health and Disease Prevention, chapter 51, Pierre Champy, Uni.
Paris-Sud, Elsevier, 2011 ; N.B. Risk of chronic neurotoxicity.
(ACG-008)
~ 95% Squamocin re: Bayer
Dr. Abbas & Dr. Arnould,
20 Feb ‘13, CLCO2E, MIR Spectra




C:CRA DATAMIRMesureATR GOLDEN GATEdiverstest democherimoya extract by CO2 - J-M Romnee.0   cherimoya extract by CO2 - J-M Romnee
                                                                                                                                 20/02/2013



                                                                 Page 1/1

More Related Content

More from Ben Rockefeller

ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990
ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990
ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990Ben Rockefeller
 
ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996
ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996
ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996Ben Rockefeller
 
ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994
ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994
ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994Ben Rockefeller
 
ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008
ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008
ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008Ben Rockefeller
 
ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005
ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005
ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005Ben Rockefeller
 
ACG-186-MOA-Cortes-ES-2005
ACG-186-MOA-Cortes-ES-2005ACG-186-MOA-Cortes-ES-2005
ACG-186-MOA-Cortes-ES-2005Ben Rockefeller
 
ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010
ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010
ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010Ben Rockefeller
 
ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994
ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994
ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994Ben Rockefeller
 
ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993
ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993
ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993Ben Rockefeller
 
ACG-008-Risk-Seeds of annona squamosa-FR-2011
ACG-008-Risk-Seeds of annona squamosa-FR-2011ACG-008-Risk-Seeds of annona squamosa-FR-2011
ACG-008-Risk-Seeds of annona squamosa-FR-2011Ben Rockefeller
 
Acetogenins In Vivo re: Wu - (p 22-36)
Acetogenins In Vivo re: Wu - (p 22-36)Acetogenins In Vivo re: Wu - (p 22-36)
Acetogenins In Vivo re: Wu - (p 22-36)Ben Rockefeller
 
Acetogenins In Vivo re: McLaughlin
Acetogenins In Vivo re: McLaughlinAcetogenins In Vivo re: McLaughlin
Acetogenins In Vivo re: McLaughlinBen Rockefeller
 

More from Ben Rockefeller (13)

ACG-Brief-ES
ACG-Brief-ESACG-Brief-ES
ACG-Brief-ES
 
ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990
ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990
ACG-149-Squamocin = Annonin I - LC-MS-IR-NMR-Bayer-DE-1990
 
ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996
ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996
ACG-117-Analysis-LC-MS Method - McLaughlin-us-1996
 
ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994
ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994
ACG-128-MOA-Acetogenins-Bullatacin-Cortes-ES-1994
 
ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008
ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008
ACG-123-Pawpaw vs. cancer-in vivo-in vitro-MOA McLaughlin-US-2008
 
ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005
ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005
ACG-221-Synthesis-Asimicin-GSK-Novartis-Pfizer-Ley-cambridge university-uk-2005
 
ACG-186-MOA-Cortes-ES-2005
ACG-186-MOA-Cortes-ES-2005ACG-186-MOA-Cortes-ES-2005
ACG-186-MOA-Cortes-ES-2005
 
ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010
ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010
ACG-185-Historic Perspective on Acetogenins-Wu-TW-2010
 
ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994
ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994
ACG-151-In vitro-MOA-Bullatacin-McLaughlin-Rabao-US-1994
 
ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993
ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993
ACG-150-In Vivo-Bullatacin-MOA-Ahammadsahib-US-1993
 
ACG-008-Risk-Seeds of annona squamosa-FR-2011
ACG-008-Risk-Seeds of annona squamosa-FR-2011ACG-008-Risk-Seeds of annona squamosa-FR-2011
ACG-008-Risk-Seeds of annona squamosa-FR-2011
 
Acetogenins In Vivo re: Wu - (p 22-36)
Acetogenins In Vivo re: Wu - (p 22-36)Acetogenins In Vivo re: Wu - (p 22-36)
Acetogenins In Vivo re: Wu - (p 22-36)
 
Acetogenins In Vivo re: McLaughlin
Acetogenins In Vivo re: McLaughlinAcetogenins In Vivo re: McLaughlin
Acetogenins In Vivo re: McLaughlin
 

ACG MIR

  • 1. Acetogenins, MIR, & Quantification of Cherimoya Leaf CO2 Extract (CLCO2E) 20 February 2013
  • 2. Can Acetogenins (in total) be Quantified by MIR ? Acetogenins from the Seeds of the Custard Apple (Annona squamosa L.) and their Health Outcomes, Nuts and Seeds in Health and Disease Prevention, chapter 51, Pierre Champy, Uni. Paris-Sud, Elsevier, 2011 ; N.B. Risk of chronic neurotoxicity. (ACG-008)
  • 3. ~ 95% Squamocin re: Bayer
  • 4. Dr. Abbas & Dr. Arnould, 20 Feb ‘13, CLCO2E, MIR Spectra C:CRA DATAMIRMesureATR GOLDEN GATEdiverstest democherimoya extract by CO2 - J-M Romnee.0 cherimoya extract by CO2 - J-M Romnee 20/02/2013 Page 1/1